13F
中

ACAD ACADIA PHARMACEUTICALS INC

2026Q1 · CUSIP 004225108 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
338
Δ holders QoQ
+3
Breadth percentile
Top 50%
Whale holders
172
Δ whales
+5
Inst. holding value
$3.7B
New positions
46
Closed positions
43
Price momentum (1Q)
-9.8%
Put / Call
7/8

Breadth history (34 quarters)

2018Q1: Δ-11 · h=198 2018Q2: Δ-12 · h=186 2018Q3: Δ-6 · h=180 2018Q4: Δ+4 · h=184 2019Q1: Δ+14 · h=198 2019Q2: Δ-2 · h=196 2019Q3: Δ+37 · h=233 2019Q4: Δ+41 · h=274 2020Q1: Δ-29 · h=245 2020Q2: Δ+52 · h=297 2020Q3: Δ-30 · h=267 2020Q4: Δ+40 · h=307 2021Q1: Δ-36 · h=271 2021Q2: Δ-26 · h=245 2021Q3: Δ-9 · h=236 2021Q4: Δ+9 · h=245 2022Q1: Δ+14 · h=259 2022Q2: Δ-15 · h=244 2022Q3: Δ-21 · h=223 2022Q4: Δ+5 · h=228 2023Q1: Δ+4 · h=232 2023Q2: Δ+2 · h=234 2023Q3: Δ+13 · h=247 2023Q4: Δ+29 · h=276 2024Q1: Δ-9 · h=267 2024Q2: Δ-1 · h=266 2024Q3: Δ-9 · h=257 2024Q4: Δ+40 · h=297 2025Q1: Δ+24 · h=321 2025Q2: Δ-7 · h=314 2025Q3: Δ+20 · h=334 2025Q4: Δ+1 · h=335 2026Q1: Δ+3 · h=338 2018Q1: holders=198 2018Q2: holders=186 2018Q3: holders=180 2018Q4: holders=184 2019Q1: holders=198 2019Q2: holders=196 2019Q3: holders=233 2019Q4: holders=274 2020Q1: holders=245 2020Q2: holders=297 2020Q3: holders=267 2020Q4: holders=307 2021Q1: holders=271 2021Q2: holders=245 2021Q3: holders=236 2021Q4: holders=245 2022Q1: holders=259 2022Q2: holders=244 2022Q3: holders=223 2022Q4: holders=228 2023Q1: holders=232 2023Q2: holders=234 2023Q3: holders=247 2023Q4: holders=276 2024Q1: holders=267 2024Q2: holders=266 2024Q3: holders=257 2024Q4: holders=297 2025Q1: holders=321 2025Q2: holders=314 2025Q3: holders=334 2025Q4: holders=335 2026Q1: holders=338 -52 -26 +0 +26 +52 162259355 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 10 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q3 Top 16% +1.3% -12.7%
2025Q1 Top 9% +13.6% +9.2%
2024Q4 Top 13% +11.4% +26.5%
2023Q4 Top 18% -41.1% -37.2%
2023Q3 Top 14% +12.6% -31.6%
2022Q1 Top 14% +0.1% -8.0%
2020Q4 Top 15% -56.8% -65.7%
2020Q2 Top 5% +30.7% +26.9%
2019Q4 Top 10% +14.6% -13.2%
2019Q3 Top 3% -0.5% +16.6%

Options Sentiment

Put holders
7
QoQ: -1
Call holders
8
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
11.5
EPS (TTM)
$2.21
EPS YoY
+61.3%
Revenue (TTM)
$1.1B
Revenue YoY
+9.9%
Quarterly Revenue & EPS (4Y)
2022-06-30: $135M 2022-09-30: $131M 2022-12-31: $136M 2023-03-31: $118M 2023-06-30: $165M 2023-09-30: $212M 2023-12-31: $231M 2024-03-31: $206M 2024-06-30: $242M 2024-09-30: $250M 2024-12-31: $260M 2025-03-31: $244M 2025-06-30: $265M 2025-09-30: $279M 2025-12-31: $284M 2026-03-31: $268M 2023-03-31: EPS -0.27 2023-06-30: EPS 0.01 2023-09-30: EPS -0.40 2023-12-31: EPS 0.28 2024-03-31: EPS 0.10 2024-06-30: EPS 0.20 2024-09-30: EPS 0.20 2024-12-31: EPS 0.86 2025-03-31: EPS 0.11 2025-06-30: EPS 0.16 2025-09-30: EPS 0.42 2025-12-31: EPS 1.61 2026-03-31: EPS 0.02 0M 142M 284M $M -0.44 0.67 1.77 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 16 2024-06-30: PE 85.62024-09-30: PE 21.52024-12-31: PE 14.72025-03-31: PE 16.22025-06-30: PE 192025-09-30: PE 15.52025-12-31: PE 9.62026-03-31: PE 9.7 9 49 90 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)